Further to our email notification to all attendees on the 26th of March we can confirm that BOS Basel 2020 will be rescheduled, and new dates are as follows: BOS Basel 2021, 29th and 30th of June, Congress Centre Basel.

This decision is in response to the unprecedented global situation presented by Covid 19. We would like to thank all stakeholders for their support. Stay safe and we look forward to working with you to return with a stellar BOS Basel 2021.

Our BOS Basel 2021 website is now live: click here to view it now.

Welcome

...to Biotech Outsourcing Strategies Basel 2020

Launched in 2006 by Bio2Business Ltd, the Biotech Outsourcing Strategies Events bring together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships and forge new buyer/supplier business relationships. The established BOS Formula is built on 4 key pillars; Exhibition showcasing international CROs and CMOs; High Quality Content (delivered through the multi-stream programme); 1-to-1 Partnering; Informal Networking (BOS Events are known for being friendly, intimate events, which create the perfect conditions for networking!).

Since 2016 we are pleased to call Basel our home of our summer event (we run a sister event in Manchester, UK, in November 2020). Located in the heart of Europe, Basel is a unique Life Science Ecosystem which we are proud to support. BOS Basel 2020 will cover Discovery Outsourcing, Small Molecule CMC Outsourcing and Biologics CMC Outsourcing.

Featured Speaker

Working with CMOs to Develop a Robust Manufacturing Strategy for Recombinant Virus Vectors

, Senior Director, Head Medicinal Chemistry, IMED RIA, AstraZeneca

ABSTRACT: At GenSight Biologics, we have been working to accelerate cycle times and manage regulatory compliance from early development (preclinical to first- in- man) to commercial to provide to the patients beneficial solutions for counteracting the effect of rare and irreversible vision loss that can lead to legal blindness in very short time after the onset of the disease.

This presentation highlights the CMC strategy we have developed in the context of operational outsourcing to key suppliers including analytical, process development, manufacturing, and supply chain.

The... Click here to Read More